GE HealthCare Technologies Inc (GEHC) is undervalued and Stryker Corp (SYK) is overvalued.
Against our estimates of intrinsic value, GEHC trades at the wider discount: a margin of safety of +29%, against -35% for SYK.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 9.1% (average of 3 methods) values the shares at $93.41; the price of $66.27 is 29% below that value, and 75% of that value comes from beyond year five.
Leak Score 63/100 on 5 of 12 signals
Discounting its cash flows at 8.7% (average of 3 methods) values the shares at $204.41; the price of $275.09 is 35% above that value, and 77% of that value comes from beyond year five.
Leak Score 65/100 on 10 of 12 signals
| Metric | GEHC | SYK |
|---|---|---|
| Verdict | Undervalued | Overvalued |
| Price | $66.27 | $275.09 |
| Intrinsic value | $93.41 | $204.41 |
| Margin of safety | +29% | -35% |
| Leak Score | 63/100 (5/12) | 65/100 (10/12) |
| Market cap | $29.9B | $105.5B |
| Revenue growth, 5 years | 3.7% | 11.8% |
| Operating margin | 13.7% | 24.3% |
| Net margin | 9.3% | 14.4% |
| Return on equity | 19.2% | 16.5% |
| Debt to equity | 0.96 | 0.64 |
| P/E | 15.2x | 28.5x |
| Forward P/E | 12.2x | 16.4x |
| P/B | 2.7x | 4.4x |
| Dividend yield | 0.2% | 1.3% |